CICERO, N.Y.— An Albany-based pharmaceutical company that's part of a $250 million economic development project in Buffalo is shutting down its Syracuse- area research center, eliminating 45 jobs. Albany Molecular Research Inc. announced Wednesday that it will close its 12- year-old facility in Cicero on July 15.» Read More
Dato Jespal Deol, CEO of Graphene Nanochem, explains that the group produces nano-material for a number of global blue-chip companies.
Alex Gunz, fund manager at Heptagon Capital, discusses the advances in the nanotechnology sector and where to invest.
Forget Apple, suggests celebrated bear Doug Kass of Seabreeze Partners. He likes these names instead.
Discussing whether the government's efforts for public innovation will help grow the economy, with Dedric Carter, National Science Foundation.
What follows is a list of jobs that may be prevalent in the 21st century. What they all have in common is they offer prospects to those entering the workforce for the rest of the century.